Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Zihua Wang is active.

Publication


Featured researches published by Zihua Wang.


Advanced Materials | 2015

Energy Migration Engineering of Bright Rare‐Earth Upconversion Nanoparticles for Excitation by Light‐Emitting Diodes

Yeteng Zhong; Iman Rostami; Zihua Wang; Hongjie Dai; Zhiyuan Hu

A novel Nd(3+) -sensitized upconversion nanoparticle (UCNP) that can be excited by near-infrared 740 nm light-emitting diode (LED) lamps with bright upconversion luminescence is designed. Yb(3+) ion distribution is engineered to increase the energy migration efficiency. The benefit of the novel LED-excited UCNPs is demonstrated by imaging of breast cancer cells and enabling an economic handheld semiquantitative visual measurement device.


Analytical Chemistry | 2015

Microarray Based Screening of Peptide Nano Probes for HER2 Positive Tumor

Zihua Wang; Weizhi Wang; Xiangli Bu; Zewen Wei; Lingling Geng; Yue Wu; Chengyan Dong; Liqiang Li; Di Zhang; Shu Yang; Fan Wang; Christopher Lausted; Leroy Hood; Zhiyuan Hu

Peptides are excellent biointerface molecules and diagnostic probes with many advantages such as good penetration, short turnover time, and low cost. We report here an efficient peptide screening strategy based on in situ single bead sequencing on a microarray. Two novel peptides YLFFVFER (H6) and KLRLEWNR (H10) specifically binding to the tumor biomarker human epidermal growth factor receptor 2 (HER2) with aKD of 10(-8) M were obtained from a 10(5) library. Conjugated to nanoparticles, both the H6 and H10 probes showed specific accumulation in HER2-positive tumor tissues in xenografted mice by in vivo imaging.


Analytical Chemistry | 2014

Bimodal Imprint Chips for Peptide Screening: Integration of High-Throughput Sequencing by MS and Affinity Analyses by Surface Plasmon Resonance Imaging

Weizhi Wang; Menglin Li; Zewen Wei; Zihua Wang; Xiangli Bu; Wenjia Lai; Shu Yang; He Gong; Hui Zheng; Yuqiao Wang; Ying Liu; Qin Li; Qiaojun Fang; Zhiyuan Hu

Peptide probes and drugs have widespread applications in disease diagnostics and therapy. The demand for peptides ligands with high affinity and high specificity toward various targets has surged in the biomedical field in recent years. The traditional peptide screening procedure involves selection, sequencing, and characterization steps, and each step is manual and tedious. Herein, we developed a bimodal imprint microarray system to embrace the whole peptide screening process. Silver-sputtered silicon chip fabricated with microwell array can trap and pattern the candidate peptide beads in a one-well-one-bead manner. Peptides on beads were photocleaved in situ. A portion of the peptide in each well was transferred to a gold-coated chip to print the peptide array for high-throughput affinity analyses by surface plasmon resonance imaging (SPRi), and the peptide left in the silver-sputtered chip was ready for in situ single bead sequencing by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS). Using the bimodal imprint chip system, affinity peptides toward AHA were efficiently screened out from the 7 × 10(4) peptide library. The method provides a solution for high efficiency peptide screening.


Analytical Chemistry | 2014

Rapid Screening of Peptide Probes through In Situ Single-Bead Sequencing Microarray

Weizhi Wang; Zewen Wei; Di Zhang; Huailei Ma; Zihua Wang; Xiangli Bu; Menglin Li; Lingling Geng; Christopher Lausted; Leroy Hood; Qiaojun Fang; Hao Wang; Zhiyuan Hu

Peptide ligands as targeting probes for in vivo imaging and drug delivery have attracted great interest in the biomedical community. However, high affinity and specificity screening of large peptide libraries remains a tedious process. Here, we report a continuous-flow microfluidic method for one-bead-one-compound (OBOC) combinatorial peptide library screening. We screened a library with 2 × 10(5) peptide beads within 4 h and discovered 140 noncanonical peptide hits targeting the tumor marker, aminopeptidase N (APN). Using the Clustal algorithm, we identified the conserved sequence Tyr-XX-Tyr in the N terminal. We demonstrated that the novel sequence YVEYHLC peptides have both nanomolar affinity and high specificity for APN in ex vivo and in vivo models. We envision that the successful demonstration of this integrated novel nanotechnology for peptide screening and identification open a new avenue for rapid discovery of new peptide-based reagents for disease diagnostics and therapeutics.


Talanta | 2015

Label-free detection microarray for novel peptide ligands screening base on MS-SPRi combination.

Weizhi Wang; Di Zhang; Zewen Wei; Zihua Wang; Xiangli Bu; Shu Yang; Qiaojun Fang; Zhiyuan Hu

Peptides ligands with high affinity and high specificity towards specific targets is catching a good deal of interests in biomedical field. Traditional peptide screening procedure involves selection, sequencing and characterization and each step is time-consuming and labor-intensive. The combination between different analytical methods could provide an integrated plan for efficient peptide screening. We report herein a label-free detection microarray system to facilitate the whole one-bead-one-compound (OBOC) peptide screening process. A microwell array chip with two identical units can trap the candidate peptide beads in one-well-one-bead manner. Peptides on beads were photo-released in situ in the well and partly transferred to two identical chips for Surface Plasmon Resonance imaging (SPRi), and peptide left in the bi-unit microwell array chip was remain for in situ single bead sequencing by matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF-MS). Using the bi-unit imprinted chip system, affinity peptides towards AD protein were efficiently screened out both qualitatively and quantitatively from 10(4) candidates. The method provides a universal solution for high efficiency and high throughput ligands screening.


Lab on a Chip | 2013

An automated Teflon microfluidic peptide synthesizer

Hui Zheng; Weizhi Wang; Xiao-Jun Li; Zihua Wang; Leroy Hood; Christopher Lausted; Zhiyuan Hu

We present a microfluidic synthesizer made entirely of Teflon material for solid phase peptide synthesis (SPPS). Solvent-resistant perfluoroalkoxy (PFA) was used to construct chip-sized devices featuring multiple tri-layer pneumatic microvalves. Using these devices, model peptides were automatically synthesized and cleaved in situ in a continuous-flow manner. The total coupling and cleavage time was significantly reduced compared to conventional bulk reactors. The synthesis of a decapeptide, for instance, took less than 6 h using our device while it usually takes more than three days using conventional reactors.


Journal of Materials Research | 2000

Effect of interfacial reaction on tensile and creep behaviors of aluminum-borate-whisker-reinforced AA6061 composite

Z.Y. Ma; S. C. Tjong; L. Geng; Zihua Wang

Aluminum-borate (AlBO) whisker-reinforced AA6061 composite fabricated by squeeze casting was subjected to both tensile and creep investigations. The whisker exhibited a significant reinforcing effect on as-extruded AA6061, but not for TG-treated specimen. The yield strength of the composite decreased slightly after T6 treatment. This was caused by the degradation of the whiskers and microcrack initiation. The incorporation of the AlBO whisker into the AA6061 improved the creep resistance of the alloy by several orders of magnitude. Moreover, the composite exhibited higher values of apparent stress exponent and apparent activation energy for both the static and cyclic creep. Finally, cyclic creep retardation behavior was observed for both reinforced and unreinforced AA6061.


ACS Medicinal Chemistry Letters | 2016

Micromixer Based Preparation of Functionalized Liposomes and Targeting Drug Delivery

Xiangqian Jia; Weizhi Wang; Qiuju Han; Zihua Wang; Yunhong Jia; Zhiyuan Hu

We present here a specific targeting nanocarrier system by functionalization of liposomes with one new type of breast cancer targeting peptide (H6, YLFFVFER) by a micromixer with high efficiency. Antitumor drugs could be successfully delivered into human epidermal growth factor receptor 2 (HER2) positive breast cancer cells with high efficiency in both in vivo and ex vivo models.


Theranostics | 2016

HER2 Targeting Peptides Screening and Applications in Tumor Imaging and Drug Delivery.

Lingling Geng; Zihua Wang; Xiangqian Jia; Qiuju Han; Zhichu Xiang; Dan Li; Xiaoliang Yang; Di Zhang; Xiangli Bu; Weizhi Wang; Zhiyuan Hu; Qiaojun Fang

Herein, computational-aided one-bead-one-compound (OBOC) peptide library design combined with in situ single-bead sequencing microarray methods were successfully applied in screening peptides targeting at human epidermal growth factor receptor-2 (HER2), a biomarker of human breast cancer. As a result, 72 novel peptides clustered into three sequence motifs which are PYL***NP, YYL***NP and PPL***NP were acquired. Particularly one of the peptides, P51, has nanomolar affinity and high specificity for HER2 in ex vivo and in vivo tests. Moreover, doxorubicin (DOX)-loaded liposome nanoparticles were modified with peptide P51 or P25 and demonstrated to improve the targeted delivery against HER2 positive cells. Our study provides an efficient peptide screening method with a combination of techniques and the novel screened peptides with a clear binding site on HER2 can be used as probes for tumor imaging and targeted drug delivery.


Theranostics | 2015

Structure-based Design of Peptides with High Affinity and Specificity to HER2 Positive Tumors.

Lingling Geng; Zihua Wang; Xiaoliang Yang; Dan Li; Wenxi Lian; Zhichu Xiang; Weizhi Wang; Xiangli Bu; Wenjia Lai; Zhiyuan Hu; Qiaojun Fang

To identify peptides with high affinity and specificity against human epidermal growth factor receptor 2 (HER2), a series of peptides were designed based on the structure of HER2 and its Z(HER2:342) affibody. By using a combination protocol of molecular dynamics modeling, MM/GBSA binding free energy calculations, and binding free energy decomposition analysis, two novel peptides with 27 residues, pep27 and pep27-24M, were successfully obtained. Immunocytochemistry and flow cytometry analysis verified that both peptides can specifically bind to the extracellular domain of HER2 protein at cellular level. The Surface Plasmon Resonance imaging (SPRi) analysis showed that dissociation constants (KD) of these two peptides were around 300 nmol/L. Furthermore, fluorescence imaging of peptides against nude mice xenografted with SKBR3 cells indicated that both peptides have strong affinity and high specificity to HER2 positive tumors.

Collaboration


Dive into the Zihua Wang's collaboration.

Top Co-Authors

Avatar

Xiangli Bu

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lingling Geng

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Qiaojun Fang

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Huailei Ma

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Iman Rostami

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Leroy Hood

University of Washington

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Chengyan Dong

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge